Jpmorgan Chase & CO Legend Biotech Corp Transaction History

Jpmorgan Chase & CO

  • $1.27 Trillion
  • Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Legend Biotech Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 318,943 shares of LEGN stock, worth $10.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
318,943
Previous 998,016 68.04%
Holding current value
$10.3 Million
Previous $32.5 Million 66.68%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
SELL
$31.43 - $39.7 $21.3 Million - $27 Million
-679,073 Reduced 68.04%
318,943 $10.8 Million
Q4 2024

Feb 12, 2025
BUY
$32.49 - $50.28 $20.6 Million - $31.9 Million
634,990 Added 174.92%
998,016 $32.5 Million
Q3 2024

Dec 26, 2024
BUY
$43.55 - $59.88 $308,246 - $423,830
7,078 Added 1.99%
363,026 $17.7 Million
Q3 2024

Nov 08, 2024
BUY
$43.55 - $59.88 $308,246 - $423,830
7,078 Added 1.99%
363,026 $17.7 Million
Q2 2024

Dec 26, 2024
SELL
$39.5 - $57.22 $279,581 - $405,003
-7,078 Reduced 1.95%
355,948 $15.8 Million
Q2 2024

Aug 12, 2024
SELL
$39.5 - $57.22 $1.63 Million - $2.36 Million
-41,251 Reduced 10.39%
355,948 $15.8 Million
Q1 2024

Dec 26, 2024
BUY
$55.06 - $69.99 $1.88 Million - $2.39 Million
34,173 Added 9.41%
397,199 $22.3 Million
Q1 2024

May 10, 2024
SELL
$55.06 - $69.99 $5.06 Million - $6.43 Million
-91,927 Reduced 18.79%
397,199 $22.3 Million
Q4 2023

Dec 26, 2024
BUY
$57.25 - $69.74 $7.22 Million - $8.79 Million
126,100 Added 34.74%
489,126 $29.4 Million
Q4 2023

Feb 12, 2024
BUY
$57.25 - $69.74 $2.14 Million - $2.6 Million
37,301 Added 8.26%
489,126 $29.4 Million
Q3 2023

Nov 14, 2023
SELL
$63.16 - $76.5 $7.8 Million - $9.44 Million
-123,417 Reduced 21.45%
451,825 $30.3 Million
Q2 2023

Aug 11, 2023
BUY
$46.28 - $75.01 $889,779 - $1.44 Million
19,226 Added 3.46%
575,242 $39.7 Million
Q1 2023

May 11, 2023
BUY
$43.42 - $57.37 $3.63 Million - $4.8 Million
83,615 Added 17.7%
556,016 $26.8 Million
Q4 2022

Feb 13, 2023
SELL
$38.8 - $55.46 $1.64 Million - $2.35 Million
-42,333 Reduced 8.22%
472,401 $23.6 Million
Q3 2022

Nov 14, 2022
BUY
$38.15 - $57.1 $1.46 Million - $2.19 Million
38,354 Added 8.05%
514,734 $21 Million
Q2 2022

Aug 11, 2022
BUY
$33.54 - $55.0 $2.38 Million - $3.9 Million
70,979 Added 17.51%
476,380 $26.2 Million
Q1 2022

May 11, 2022
BUY
$31.02 - $48.18 $4.88 Million - $7.58 Million
157,330 Added 63.42%
405,401 $14.7 Million
Q4 2021

Feb 10, 2022
BUY
$41.14 - $56.98 $6.18 Million - $8.56 Million
150,159 Added 153.36%
248,071 $11.6 Million
Q3 2021

Nov 12, 2021
BUY
$35.31 - $50.56 $3.46 Million - $4.95 Million
97,912 New
97,912 $4.95 Million

Others Institutions Holding LEGN

# of Institutions
238
Shares Held
59.7M
Call Options Held
591K
Put Options Held
381K
View Full List

About Legend Biotech Corp

LEGN Quotes by TradingView
  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $5.42B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email